Screening Research

Previous and current research

of CRC screening and of early detection of recurrence
– based on analyses of blood samples

 

Previous:

  • 2002:                   Publication of preliminary results from a retrospective study in Denmark
  • 2004–2005:         Endoscopy IA study: Denmark—4.509 subjects with symptoms of bowel neoplasia
  • 2005–2006:         Endoscopy IB study: Australia—2.005 subjects with symptoms of bowel neoplasia
  • 2006–2009:         Analyses of blood samples from the Endoscopy IA + IB studies
  • 2007–2010:         Monitoring study: Blood samples from 634 patients undergoing resection for primary

  colorectal cancer. Collection of blood samples preoperatively and every third month for 36

  months in total – optimal samples set: 15 collections/patient

  • 2010–2015:         Analyses of blood samples from the Monitoring study
  • 2014–2016:         Presentation of results from the Monitoring study
  • 2015–2016:         Publication of resulst from the Monitoring study
  • 2010–2012:         Endoscopy II study: Danmark—4.698 subjects with symptoms of bowel neoplasia
  • 2011:                   Publication of results from  the Endoscopy IA
  • 2012:                   Presentation of results from the Endoscopy IB (in Australia)
  • 2013–2016:         Analyses of blood samples from the Endoscopy II
  • 2015–2016:         Publications of results from the Endoscopy IA and IB

 

——————–

Current:

  • 2016–2018:        Analyses of blood samples from the Endoscopy II study
  • 2016–2019:        Publications of results from the Endoscopy II study
  • 2016–2018:        Analyses of blood samples from the Monitoring study
  • 2016–2019:        Presentations of results from the Monitoring study
  • 2017–2019:        Publications of results from the Monitoring study
  • 2014–2016:        Endoscopy III, part 1 study: Denmark—blood samples from 8,000 subjects screened FIT

 positive and 6,000 subjects screened FIT negative—completing at ultimo 2016.

  • 2016–2018:        Analyses of blood samples from the Endoscopy III, part 1 study
  • 2016–2018:        Presentation of results from the Endoscopy III, part 1 study
  • 2017–2019:        Publications of results from the Endoscopy III, part 1 study
  • 2016–2022:        Endoscopyi III, part 2 study: Denmark—blood samples from 90,000 subjects screened FIT

 negative

  • 2018–2023:        Analyses of blood samples from the 90,000 subjects
  • 2016–2023:        Current presentations and publications of results from all studies

 

 

 

Read more:

cirkel2The Triage Project             A feasibility project

The Biomarker Project      Protocol Outlines      Analyses

Print Friendly, PDF & Email

Contact:

ColoRectal Cancer Research

Gastroenheden, Hvidovre Hospital

Kettegård Allé 30

2650 Hvidovre

Email: info@colorectalcancer.dk